[Federal Register Volume 86, Number 149 (Friday, August 6, 2021)]
[Notices]
[Pages 43254-43255]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16825]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-21-1314; Docket No. CDC-2021-0077]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on the Understanding 
important issues in ovarian cancer survivorship (OCS) project. The OCS 
project aims to better understand the needs of ovarian cancer survivors 
and how to more effectively develop interventions targeted to this 
population.

DATES: CDC must receive written comments on or before October 5, 2021.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0077 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.

    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed 
above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7118; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Understanding the needs of ovarian cancer survivors. (OMB Control 
No. 0920-1314, Exp. 12/31/2021)--Extension--National Center for Chronic 
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    Ovarian cancer is the ninth most common cancer, and the fifth 
leading cause of cancer death among women in the United States. Over 
20,000 women are diagnosed with ovarian cancer each year. Due to the 
lack of a recommended screening test, ovarian cancer is often diagnosed 
at late stages, leading to low five-year survival rates. While previous 
studies are able to identify some of the needs of ovarian cancer 
survivors, particularly related to physical complications and side 
effects, additional research is needed to further understand the 
experiences and needs of survivors.
    The National Academies of Sciences, Engineering, and Medicine 
released their report, Ovarian Cancers: Evolving Paradigms in Research 
and Care, which identified key priorities for researchers, including 
recommending research on the ``supportive care needs of ovarian cancer 
survivors throughout the disease trajectory.'' In order to address 
these research gaps and supplement current knowledge of the ongoing 
needs of survivors, including how to implement

[[Page 43255]]

programs and interventions to improve their health, CDC has supported a 
survey of ovarian cancer survivors.
    The goal of this project is to better understand the needs of 
ovarian cancer survivors and how to more effectively develop 
interventions targeted to this population. To achieve this goal, 
multiple recruitment methods will be utilized to recruit this unique 
population of women for the study. By using state cancer registries, 
social media advertisements, and respondent-driven sampling (RDS), the 
study will ensure recruit of a diverse population of women.
    This study will focus on the following research questions:
    1. What physical and mental conditions do ovarian cancer survivors 
experience?
    2. What kinds of pharmacologic and non-pharmacologic interventions 
do ovarian cancer survivors utilize to manage their conditions?
    3. What barriers do ovarian cancer survivors have in accessing and 
receiving appropriate diagnostic care, treatment, and follow-up care?
    4. What unmet needs do ovarian cancer survivors have?
    The overall sample design targets 1,200 completed interviews. 
Completed surveys will come from more traditional sampling utilizing 
lists from the state cancer registries (n = 1,200). This is a request 
for an extension of two years to the data collection period. 
Participation in this study is voluntary. The total estimated annual 
burden hours are 1,000. There are no costs to respondents other than 
their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of      Avg. burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent       (in hrs)       (in hours)
----------------------------------------------------------------------------------------------------------------
Ovarian cancer survivors--      Mail-in or web-            1,200               1           50/60           1,000
 state cancer registries.        based
                                 questionnaire.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............           1,000
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2021-16825 Filed 8-5-21; 8:45 am]
BILLING CODE 4163-18-P